Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2014-11-20
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 60
- Registration Number
- NCT02296749
- Locations
- 🇮🇳
Bioserve Clinical Research Pvt. Ltd, Balanagar, Hyderabad, Andhra Pradesh, India
Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition
- First Posted Date
- 2014-11-19
- Last Posted Date
- 2014-11-19
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 80
- Registration Number
- NCT02295046
- Locations
- 🇩🇪
3S-Pharmacological Consultation & Research GmbH, D-27243 Harpstedt, Koenigsberger, Germany
Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition
- First Posted Date
- 2014-11-17
- Last Posted Date
- 2014-11-17
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 90
- Registration Number
- NCT02292069
- Locations
- 🇮🇳
Veeda Clinical Research Pvt Ltd, Ahmedabad, Gujrat, India
Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting Condition
- First Posted Date
- 2014-11-14
- Last Posted Date
- 2014-11-14
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 76
- Registration Number
- NCT02291367
- Locations
- 🇮🇳
BA Research India Ltd, Ahmedabad, Gujrat, India
Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed Condition
- First Posted Date
- 2014-11-14
- Last Posted Date
- 2014-11-14
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 76
- Registration Number
- NCT02291341
- Locations
- 🇮🇳
BA Research India Ltd, Ahmedabad, Gujrat, India
DFN-02 Open Label Safety Study in Patients With Acute Migraine
- First Posted Date
- 2014-10-30
- Last Posted Date
- 2018-03-09
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 167
- Registration Number
- NCT02279082
- Locations
- 🇺🇸
California Medical Clinic for Headache, Santa Monica, California, United States
🇺🇸Clinvest/A Division of Banyan Group, Inc., Springfield, Missouri, United States
🇺🇸Arizona Research Center, Phoenix, Arizona, United States
Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection
- Conditions
- Interventions
- First Posted Date
- 2014-10-09
- Last Posted Date
- 2016-09-23
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 49
- Registration Number
- NCT02260544
- Locations
- 🇮🇳
Dr. G. Viswanathan Speciality Hospitals, Trichy, Tamil Nadu, India
🇮🇳Meenakshi Mission Hospital & Research Centre, Madurai, Tamil Nadu, India
🇮🇳City Cancer Center, Vijaywada, Andhra Pradesh, India
A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2014-07-31
- Last Posted Date
- 2014-07-31
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 192
- Registration Number
- NCT02205320
- Locations
- 🇺🇸
QPS Bio-Kinetic, Springfield, Missouri, United States
A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2014-06-24
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 200
- Registration Number
- NCT02173301
- Locations
- 🇺🇸
XenoPort Investigational Site, West Jordan, Utah, United States
Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
- Conditions
- Interventions
- First Posted Date
- 2014-03-27
- Last Posted Date
- 2021-05-11
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 50
- Registration Number
- NCT02097485
- Locations
- 🇦🇺
National Head Lice Treatment Centre, Ringwood East, Victoria, Australia